Filter Insights by:
Learn why pharma companies should rely on biomethane as a scalable, credible, and readily available low-carbon solution to address their scope 1 footprint.
To meet ambitious climate goals, businesses need to invest in high-quality carbon removals—before it's too late.
As businesses work to address residual emissions, biochar has emerged as a key CDR solution.
Get answers to common questions about biomethane and renewable natural gas (RNG), from how it is produced and what feedstocks are used, to how companies are using it to reduce scope 1 emissions and meet net-zero targets.
Watch an overview of our methodology to credibly address scope 3 emissions through direct procurement of clean electricity attributes.
Watch a practical session exploring how the pharmaceutical industry can accelerate decarbonisation that matters most through innovative clean energy strategies.
As food and beverage corporations strive for net-zero goals, addressing scope 3 emissions is essential.
